Zydus Arm Gets Rs 284 Crore Tax Demand
Zydus Healthcare Ltd., a wholly owned subsidiary of Zydus Lifesciences Ltd., has received a tax demand of Rs 284.6 crore from the Income Tax Department for the assessment year 2023-2024.
The drugmaker's claim for deduction under sections 80-IE and 80-JJAA of the IT Act was not allowed without any basis, and it was given short credit for taxes deducted or paid, it said in an exchange filing.
Section 80JJAA is a provision that offers tax deductions to employers who generate employment in the formal sector. While the tax benefits under Section 80IE include a 100% deduction of profits and gains derived from the business of developing, maintaining, and operating the infrastructure facility for a period of 10 consecutive assessment years,.
ZHL expects the tax demand to have no material financial impact and has already disagreed with the demand on the e-filing portal of the department, it said.
The company is also going to file a 'Rectification Application' under Section 154 of the IT Act against the intimation before the department and the Jurisdictional Assessing Officer.
"The company strongly believes that once the rectification will be made, the entire demand will be deleted," the filing said.
Shares of Zydus Lifesciences closed 0.56% lower at Rs 676.15 apiece on Tuesday, ahead of the announcement, compared to a 0.32% advance in the benchmark BSE Sensex.
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.
-
India Exports Capital. Why Not Export Trusteeship?
The big question, then, is whether India can build an institution that global borrowers, investors, banks, and lawyers can trust, even without an Indian connection.
-
France's Economy & Politics Are In Crisis | The Reason Why
Let's look at how the French economy and politics evolved under Nicolas Sarkozy, Franois Hollande and Emmanuel Macron.
-
You May Inherit The Business. You Must Earn Its Credibility.
Succession tests the founder's ability to share authority as much as it tests the next generation's readiness to assume it.
-
Signing Deals Is One Thing; Making Them Work Is Another | The Week In Whys
Sometimes, things don't turn out as planned. Indian companies have lost some bids to rivals, some projects won't produce until 2030.
-
FOMC Wall, PERM Suspension, Hospital Stocks | Talking Points This Week
A PERM suspension would directly affect green-card sponsorship rather than H-1B visas, so the near-term earnings impact could remain relatively limited. The key question is whether this marks a new phase in US scrutiny of Indian IT.
-
Everything, Everywhere, All At Once: Dalal Street's Week To Forget | Joining The Dots
Visa curbs, a Starlink spat and cancer drug caps: what connects this week's shocks for Indian markets
-
India Is Going Abroad For Critical Minerals. But It May Take Years To Pay Off | The Reason Why
Although India's steps are in the right direction, they remain modest compared with India's growing dependence.
-
When Everyone Has AI, What Gives You An Edge?
India's young workforce is entering an uncertain world of work where powerful AI tools are becoming widely accessible. The advantage will belong to those who combine deep expertise with digital fluency, and the distinctly human capabilities that technology cannot manufacture.
-
Wrong Labels, High Pesticide Residues Holding Back Agri Exports | The Reason Why
India needs stronger domestic food-safety and labelling standards, with best practices becoming part of everyday business for farmers, traders and food companies.
